IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
33.19
+0.16 (0.48%)
At close: Mar 6, 2026, 4:00 PM EST
33.85
+0.66 (1.99%)
After-hours: Mar 6, 2026, 7:36 PM EST
IDEAYA Biosciences Market Cap
IDEAYA Biosciences has a market cap or net worth of $2.91 billion as of March 6, 2026. Its market cap has increased by 53.22% in one year.
Market Cap
2.91B
Enterprise Value
1.89B
1-Year Change
53.22%
Ranking
Category
Stock Price
$33.19
Market Cap Chart
Since May 23, 2019, IDEAYA Biosciences's market cap has increased from $215.57M to $2.91B, an increase of 1,252.04%. That is a compound annual growth rate of 46.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 2.91B | -3.83% |
| Dec 31, 2025 | 3.03B | 36.44% |
| Dec 31, 2024 | 2.22B | -3.15% |
| Dec 29, 2023 | 2.29B | 162.34% |
| Dec 30, 2022 | 874.22M | -3.92% |
| Dec 31, 2021 | 909.90M | 123.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Spyre Therapeutics | 3.15B |
| Denali Therapeutics | 3.12B |
| Tarsus Pharmaceuticals | 3.12B |
| Edgewise Therapeutics | 2.98B |
| Arcutis Biotherapeutics | 2.98B |
| Catalyst Pharmaceuticals | 2.96B |
| Viridian Therapeutics | 2.90B |
| Dianthus Therapeutics | 2.82B |